# Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

> **NCT05490667** · NA · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Desmoid

## Interventions

- **DRUG:** Anlotinib

## Key facts

- **NCT ID:** NCT05490667
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-20
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05490667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05490667, "Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT05490667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*